Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2026 is 31.57% vs -0.53% in Jun 2026
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2026 is -1.89% vs -22.92% in Jun 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2026 is 38.28% vs 46.16% in Jun 2026
Interest
QoQ Growth in quarter ended Sep 2026 is 35.38% vs 19.27% in Jun 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026
Compare Quarterly Results Of Natco Pharma With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2026 is 31.57% vs -0.53% in Jun 2026
YoY Growth in quarter ended Sep 2026 is -29.03% vs -0.59% in Sep 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2026 is -1.89% vs -22.92% in Jun 2026
YoY Growth in quarter ended Sep 2026 is -60.92% vs -23.46% in Sep 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2026 is 38.28% vs 46.16% in Jun 2026
YoY Growth in quarter ended Sep 2026 is -55.47% vs -27.99% in Sep 2025
Quarterly - Interest
QoQ Growth in quarter ended Sep 2026 is 35.38% vs 19.27% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 34.35% vs 219.51% in Sep 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026
YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025